BEAM
Price
$23.13
Change
+$0.41 (+1.80%)
Updated
May 3, 6:59 PM EST
4 days until earnings call
MNKD
Price
$4.39
Change
+$0.01 (+0.23%)
Updated
May 3, 6:59 PM EST
5 days until earnings call
Ad is loading...

Compare predictions BEAM vs MNKD

Header iconBEAM vs MNKD Comparison
Open Charts BEAM vs MNKDBanner chart's image
Beam Therapeutics
Price$23.13
Change+$0.41 (+1.80%)
Volume$634.55K
CapitalizationN/A
MannKind
Price$4.39
Change+$0.01 (+0.23%)
Volume$1.22M
CapitalizationN/A
View a ticker or compare two or three
BEAM vs MNKD Comparison Chart

Loading...

BEAMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
MNKDDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BEAM vs. MNKD commentary
May 03, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and MNKD is a Hold.

COMPARISON
Comparison
May 03, 2024
Stock price -- (BEAM: $22.72 vs. MNKD: $4.38)
Brand notoriety: BEAM and MNKD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 71% vs. MNKD: 53%
Market capitalization -- BEAM: $1.87B vs. MNKD: $1.18B
BEAM [@Biotechnology] is valued at $1.87B. MNKD’s [@Biotechnology] market capitalization is $1.18B. The market cap for tickers in the [@Biotechnology] industry ranges from $559.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.61B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileMNKD’s FA Score has 2 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • MNKD’s FA Score: 2 green, 3 red.
According to our system of comparison, MNKD is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while MNKD’s TA Score has 5 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 4 bearish.
  • MNKD’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both BEAM and MNKD are a good buy in the short-term.

Price Growth

BEAM (@Biotechnology) experienced а +5.19% price change this week, while MNKD (@Biotechnology) price change was +4.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.27%. For the same industry, the average monthly price growth was -0.50%, and the average quarterly price growth was +1243.13%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 06, 2024.

MNKD is expected to report earnings on Aug 07, 2024.

Industries' Descriptions

@Biotechnology (+5.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BEAM with price predictions.
OPEN
A.I.dvisor published
a Summary for MNKD with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
BEAM($1.87B) has a higher market cap than MNKD($1.18B). MNKD YTD gains are higher at: 20.330 vs. BEAM (-16.532).
BEAMMNKDBEAM / MNKD
Capitalization1.87B1.18B158%
EBITDAN/AN/A-
Gain YTD-16.53220.330-81%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
MNKD: Fundamental Ratings
MNKD
OUTLOOK RATING
1..100
18
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
PROFIT vs RISK RATING
1..100
40
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
31
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMMNKD
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
N/A
Stochastic
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
87%
Declines
ODDS (%)
Bearish Trend 8 days ago
87%
Bearish Trend 18 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
78%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
70%
View a ticker or compare two or three
Ad is loading...
BEAMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
MNKDDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CCHRX72.740.80
+1.11%
Columbia Seligman Global Tech Adv
SFGCX13.080.10
+0.77%
Guggenheim World Equity Income C
TRMCX33.070.12
+0.36%
T. Rowe Price Mid-Cap Value
WASMX23.040.07
+0.30%
Boston Trust Walden SMID Cap
ISCRX13.56N/A
N/A
AB International Low Volatility Eq PortC